Luca Licata

6PUBLICATIONS
23CO-AUTHORS
Clinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersPanel data analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Low Rates of Discontinuation Unrelated to Disease Progression with Trastuzumab Deruxtecan in Metastatic Breast Cancer: A Real-World Study.

|Jul 21, 2025
Timing of Recurrence after Neoadjuvant Chemo-Immunotherapy in Patients with Early-Stage Triple-Negative Breast Cancer.

Luca Licata, Marco Mariani, Giulia Viale

|Jan 24, 2024
Real-world use of multigene signatures in early breast cancer: differences to clinical trials.

Luca Licata, Rita De Sanctis, Andrea Vingiani

|Nov 07, 2023
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy.

Luca Licata, Marco Barreca, Barbara Galbardi

|Jun 08, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer.

Luca Licata, Giulia Viale, Mario Giuliano

|May 16, 2020
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.

Giulia Viale, Luca Licata, Lorenzo Sica

Pageof 1

Frequent Collaborators

5 joint publications

Giampaolo Bianchini

3 joint publications

Lajos Pusztai

2 joint publications

Marco Mariani

1 joint publications

Giuseppe Curigliano